BLDE Overview

• Third Point's Investment Strategy: Dan Loeb's Third Point LLC significantly increased its stake in tech stocks, notably boosting its holdings in Microsoft by 175% and Meta by 47% during Q3 2025.

• Exits from Holdings: The firm fully exited its position in Workday, selling its remaining shares, and also divested from several other companies including Danaher and Apollo Global Management.

• Stake Reductions: Third Point reduced its stakes in various companies, with notable decreases in Live Nation Entertainment (-32%) and Jacobs Solutions (-28%).

• Top Holdings: As of Q3 2025, Third Point's top five holdings included Pacific Gas & Electric, Amazon, Microsoft, Nvidia, and Norfolk Southern Corporation.

Company Announcement

• Presentation at Jefferies Conference: Strata Critical Medical, Inc. (formerly Blade Air Mobility, Inc.) will have Co-CEO and CFO Will Heyburn present at the 2025 Jefferies Industrials Conference on September 4, 2025, at 11:30 AM ET. A webcast of the event will be available, with a replay accessible on the company's investor relations website.

About Strata Critical Medical

• Business Overview: Strata Critical Medical specializes in time-critical logistics and medical services for healthcare providers in the U.S. The company is expanding its service portfolio through acquisitions and organic growth.
• Trinity Medical Solutions: A subsidiary of Strata, Trinity Medical Solutions is a leader in the air and ground transportation of human organs for transplant, utilizing an asset-light platform to provide reliable logistics solutions.

Forward-Looking Statements

• Nature of Statements: The press release includes forward-looking statements that are not historical facts, indicating potential future performance and strategies. These statements involve risks and uncertainties that could lead to actual results differing from expectations.
• Risks and Uncertainties: Factors affecting future performance include unexpected costs from divestitures, market growth challenges, competition, regulatory changes, and operational risks. The company advises caution in relying on these forward-looking statements, which are subject to change.

Company Transition and Divestiture

• Divestiture Details: Strata Critical Medical, Inc. has successfully completed the divestiture of its Passenger business to Joby Aviation, Inc. Joby will pay the initial consideration in stock and may provide up to an additional $35 million based on employee retention and financial performance targets over the next 18 and 12 months, respectively. There is also a potential release of up to $10 million in indemnity holdbacks, payable in cash or stock at Joby’s discretion.

• Rebranding Announcement: The company has officially rebranded from Blade Air Mobility, Inc. to Strata Critical Medical, now trading under the ticker symbol SRTA. This change reflects a complete focus on organ logistics and medical services.

Strategic Focus and Growth Plans

• Market Positioning: Strata aims to leverage its industry-leading organ transplant logistics platform, emphasizing rapid response times and cost efficiency through an asset-light aircraft network. The company is positioned to expand its services in the medical logistics sector.

• Growth Strategy: Co-CEO Will Heyburn highlighted a unique 'one-call' logistics solution that allows Strata to procure various services from third parties, creating multiple growth opportunities through organic growth, strategic partnerships, and acquisitions.

Financial Outlook

• 2025 Revenue Projections: Strata has updated its financial guidance for 2025, projecting revenues between $160 million and $170 million, alongside a double-digit Adjusted EBITDA.

• Cost Management: The company anticipates a reduction in adjusted unallocated corporate expenses and software development costs to approximately $3.5 million per quarter by Q4 2025.

Future Engagements

• Investor Day Announcement: Strata plans to hold an investor day in the fall, with further details to be provided in the coming weeks, indicating a commitment to transparency and engagement with stakeholders.

Company Overview

• Core Services: Strata Critical Medical specializes in time-critical logistics solutions and medical services for healthcare providers across the U.S., with its subsidiary, Trinity Medical Solutions, leading in the transportation of human organs for transplant.

Forward-Looking Statements

• Caution on Predictions: The press release includes forward-looking statements that involve risks and uncertainties, emphasizing that actual results may differ significantly from projections due to various factors, including market conditions and operational challenges.

• Company Name Change: Blade Air Mobility has officially changed its name to Strata Critical Medical to focus on logistics and medical services for healthcare providers after selling its Passenger business to Joby Aviation.

• Partnership with Joby Aviation: Strata Critical Medical will partner with Joby Aviation as its preferred VTOL provider for organ transport, enhancing its capabilities in the organ transport market.

• Market Positioning: The company currently manages about 90% of time-critical logistics in the U.S. organ transport sector and aims to leverage electric vertical takeoff and landing aircraft to reduce operational costs significantly.

• Leadership and Trading Symbol: Strata Critical Medical is now led by co-CEOs Will Heyburn and Melissa Tomkiel, and it will begin trading under the new symbol 'SRTA'.

• Company Name Change: Blade Air Mobility will change its name to Strata Critical Medical, Inc. on August 28, 2025, as part of a strategic shift towards medical and logistics services.

• New Ticker Symbols: From August 29, the company's shares will be traded under the new ticker "SRTA" and its warrants under "SRTAW" on the Nasdaq.

• Business Transition: The rebranding coincides with the pending sale of Blade's passenger business to Joby Aviation.

• Related Developments: The announcement is part of broader industry movements involving Joby Aviation, which has been making headlines for various operational advancements and partnerships.

• Joby Aviation's Progress: Joby Aviation is advancing towards commercial operations with its eVTOL aircraft, having recently completed a significant flight between two public airports and planning to acquire Blade Air Mobility for market access.

• Vertical Aerospace's Position: Vertical Aerospace, trading at a low market cap compared to U.S. peers, is working on certification with the U.K. and EU authorities and has secured 1,500 preorders for its aircraft, indicating potential growth despite financial challenges.

• Ark Space Exploration & Innovation ETF Performance: The Ark Space Exploration & Innovation ETF has seen substantial gains of 36.2% year-to-date and 78% over the past year, focusing on companies involved in space exploration and related technologies, including eVTOL firms.

• Investment Considerations: While Joby Aviation shows promise, it was not included in the Motley Fool Stock Advisor's top stock picks, which highlights other stocks that may offer better returns based on historical performance.